1. Home
  2. NTRA vs NWSA Comparison

NTRA vs NWSA Comparison

Compare NTRA & NWSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • NWSA
  • Stock Information
  • Founded
  • NTRA 2003
  • NWSA 2012
  • Country
  • NTRA United States
  • NWSA United States
  • Employees
  • NTRA N/A
  • NWSA N/A
  • Industry
  • NTRA Medical Specialities
  • NWSA Newspapers/Magazines
  • Sector
  • NTRA Health Care
  • NWSA Consumer Discretionary
  • Exchange
  • NTRA Nasdaq
  • NWSA Nasdaq
  • Market Cap
  • NTRA 13.7B
  • NWSA 16.1B
  • IPO Year
  • NTRA 2015
  • NWSA N/A
  • Fundamental
  • Price
  • NTRA $129.95
  • NWSA $26.02
  • Analyst Decision
  • NTRA Strong Buy
  • NWSA Strong Buy
  • Analyst Count
  • NTRA 15
  • NWSA 4
  • Target Price
  • NTRA $123.64
  • NWSA $35.00
  • AVG Volume (30 Days)
  • NTRA 1.2M
  • NWSA 2.2M
  • Earning Date
  • NTRA 11-06-2024
  • NWSA 11-07-2024
  • Dividend Yield
  • NTRA N/A
  • NWSA 0.77%
  • EPS Growth
  • NTRA N/A
  • NWSA 77.95
  • EPS
  • NTRA N/A
  • NWSA 0.46
  • Revenue
  • NTRA $1,360,503,000.00
  • NWSA $10,085,000,000.00
  • Revenue This Year
  • NTRA $42.99
  • NWSA $5.25
  • Revenue Next Year
  • NTRA $13.11
  • NWSA $3.62
  • P/E Ratio
  • NTRA N/A
  • NWSA $56.83
  • Revenue Growth
  • NTRA 46.13
  • NWSA 2.09
  • 52 Week Low
  • NTRA $36.90
  • NWSA $19.25
  • 52 Week High
  • NTRA $128.28
  • NWSA $28.62
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 66.43
  • NWSA 38.81
  • Support Level
  • NTRA $114.62
  • NWSA $25.72
  • Resistance Level
  • NTRA $118.52
  • NWSA $26.26
  • Average True Range (ATR)
  • NTRA 4.62
  • NWSA 0.53
  • MACD
  • NTRA 0.87
  • NWSA -0.17
  • Stochastic Oscillator
  • NTRA 99.77
  • NWSA 15.22

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About NWSA News Corporation

News Corporation is a diversified media conglomerate with significant presence in the us, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. The company also has a strong presence in the Australian subscription video market through 65%-owned Foxtel, and streaming platforms such as sport-focused Kayo and entertainment-focused Binge. Its 61%-owned REA Group is the dominant property listings business in Australia. In addition, it owns Harper Collins, one of the biggest book publishers in the world, and has a sizable us digital property advertising business, Move.

Share on Social Networks: